MX9603611A - X-ray contrast compositions containing cellulose derivatives. - Google Patents

X-ray contrast compositions containing cellulose derivatives.

Info

Publication number
MX9603611A
MX9603611A MX9603611A MX9603611A MX9603611A MX 9603611 A MX9603611 A MX 9603611A MX 9603611 A MX9603611 A MX 9603611A MX 9603611 A MX9603611 A MX 9603611A MX 9603611 A MX9603611 A MX 9603611A
Authority
MX
Mexico
Prior art keywords
ray contrast
compositions containing
cellulose derivatives
containing cellulose
contrast compositions
Prior art date
Application number
MX9603611A
Other languages
Spanish (es)
Inventor
Carl R Illig
John Toner
Edward James Baker
Robert Lee
Tom Caulfield
Brent D Douty
Kurt Josef
Edward R Bacon
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/201,731 external-priority patent/US5422114A/en
Priority claimed from US08/206,552 external-priority patent/US5443814A/en
Priority claimed from US08/217,138 external-priority patent/US5385721A/en
Priority claimed from US07/216,988 external-priority patent/US5385720A/en
Priority claimed from US08/222,787 external-priority patent/US5466435A/en
Priority claimed from US08/227,415 external-priority patent/US5525327A/en
Priority claimed from US08/227,423 external-priority patent/US5368837A/en
Priority claimed from US08/227,422 external-priority patent/US5543132A/en
Priority claimed from US08/229,048 external-priority patent/US5385722A/en
Priority claimed from US08/246,888 external-priority patent/US5607660A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of MX9603611A publication Critical patent/MX9603611A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration

Abstract

Disclosed are x-ray contrast compositions for oral or retrograde examination of the gastrointestinal tract comprising an x-ray contrast producing agent in a pharmaceutically acceptable carrier comprising a cellulose derivative.
MX9603611A 1994-02-25 1995-02-24 X-ray contrast compositions containing cellulose derivatives. MX9603611A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US08/201,731 US5422114A (en) 1993-03-01 1994-02-25 Compositions of iodoaniline derivatives and cellulose derivatives for visualization of the gastrointestinal tract
US08/206,552 US5443814A (en) 1992-05-01 1994-03-04 X-ray contrast compositions containing iodophenoxyalkanes and cellulose derivatives
US08/217,138 US5385721A (en) 1993-02-04 1994-03-22 Compositions of alkylbenzenes and cellulose derivatives for visualization of the gastrointestinal tract
US07/216,988 US5385720A (en) 1993-03-11 1994-03-23 Compositions of iodobenzoic acid derivatives and cellulose derivatives for visualization of the gastrointestinal tract
US08/222,787 US5466435A (en) 1993-03-11 1994-04-04 Compositions of iodophenoxy alkylene ethers and cellulose derivatives for visualization of the gastrointestinal tract
US08/227,415 US5525327A (en) 1994-04-14 1994-04-14 Polymeric x-ray contrast compositions containing iodinated polymeric beads and microcrystaline cellulose
US08/227,423 US5368837A (en) 1994-04-14 1994-04-14 X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
US08/227,422 US5543132A (en) 1994-04-14 1994-04-14 X-ray contrast compositions containing a barium salt and a cellulose derivative
US08/229,048 US5385722A (en) 1993-03-31 1994-04-18 Compositions of iodophenyl esters and iodophenyl sulfonates and cellulose derivatives for visualization of the gastrointestinal tract
US08/246,888 US5607660A (en) 1993-02-02 1994-05-20 Compositions of iodophenoxy alkanes and iodophenyl ethers in combination with cellulose derivatives for visualization of the gastrointestinal tract
PCT/GB1995/000386 WO1995022995A1 (en) 1994-02-25 1995-02-24 X-ray contrast compositions containing cellulose derivatives

Publications (1)

Publication Number Publication Date
MX9603611A true MX9603611A (en) 1997-04-30

Family

ID=27581136

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603611A MX9603611A (en) 1994-02-25 1995-02-24 X-ray contrast compositions containing cellulose derivatives.

Country Status (10)

Country Link
EP (1) EP0746339A1 (en)
JP (1) JPH09509424A (en)
CN (1) CN1146159A (en)
AU (1) AU1816395A (en)
CA (1) CA2184089A1 (en)
FI (1) FI963299A0 (en)
HU (1) HUT76336A (en)
MX (1) MX9603611A (en)
NO (1) NO963540L (en)
WO (1) WO1995022995A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603547D0 (en) * 1996-02-20 1996-04-17 Nycomed Imaging As Contrast media
CA2481692A1 (en) * 2002-04-06 2003-10-23 E-Z-Em, Inc. Method for tagging colonic residue
US20110158909A1 (en) * 2008-02-01 2011-06-30 Trustees Of Boston University Cationic Contrast Agents and Methods of Use Thereof
CN105142680A (en) 2013-03-15 2015-12-09 加利福尼亚大学董事会 Enteric ct contrast material based on low-Z atoms
CN117018234A (en) 2013-08-16 2023-11-10 加利福尼亚大学董事会 Silicone-based intestinal CT contrast material
WO2017165841A1 (en) * 2016-03-25 2017-09-28 Nanoprobes, Inc. Iodine-based particles
CN109540936A (en) * 2019-01-11 2019-03-29 大连大学附属中山医院 It is a kind of for high-resolution ct and the room temperature contrast agent of x-ray artery, vein or pipeline and preparation method thereof
AU2021416061A1 (en) * 2020-12-28 2023-06-08 Boston Scientific Scimed, Inc. Polysaccharides having improved radiocontrast properties

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (en) * 1954-01-08 1959-05-15 Schering Corp Use as radiopaque agents of polyiodinated phenoxy fatty acids
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
US4406878A (en) * 1978-08-02 1983-09-27 Eastman Kodak Company Iodinated contrast agent for radiography
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
US5342605A (en) * 1992-05-01 1994-08-30 Sterling Winthrop Inc. Polymeric X-ray compositions containing iodinated polymeric beads
WO1994005336A1 (en) * 1992-09-01 1994-03-17 Sterling Wintrop Inc. Film-forming x-ray contrast compositions
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5330740A (en) * 1993-03-01 1994-07-19 Sterling Winthrop Inc. Compositions of iodoaniline derivatives in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract

Also Published As

Publication number Publication date
NO963540L (en) 1996-10-23
JPH09509424A (en) 1997-09-22
FI963299A (en) 1996-08-23
AU1816395A (en) 1995-09-11
FI963299A0 (en) 1996-08-23
HUT76336A (en) 1997-08-28
CN1146159A (en) 1997-03-26
NO963540D0 (en) 1996-08-23
WO1995022995A1 (en) 1995-08-31
HU9602321D0 (en) 1996-10-28
EP0746339A1 (en) 1996-12-11
CA2184089A1 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
HUP9900183A3 (en) Oral fast-dissolving pharmaceutical compositions for dopamine agonists
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
AU7888791A (en) Patient evacuation envelope
HUP9900625A3 (en) Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
HUP9802629A3 (en) Use of 1,3-bis(1,2,4-triazolyl)propan-2-ol derivatives for the manufacture of pharmaceutical compositions treating cancers
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
MX9603611A (en) X-ray contrast compositions containing cellulose derivatives.
ZA963584B (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
HUP9802634A3 (en) Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia
CA2116829A1 (en) Use of a pregnane derivative
PL307469A1 (en) Preparation for oral administration
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
AU1897795A (en) X-ray contrast compositions containing pharmaceutically acceptable clays
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
AU2823795A (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging
AU7735798A (en) Pharmaceutical composition for oral administration
AU3257095A (en) Deuterium-containing pharmaceutical compositions for destroying tumors